List of Tables
Table 1. Global Rare Disease Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biologics
Table 3. Key Players of Biosimilar
Table 4. Key Players of Small Molecules
Table 5. Global Rare Disease Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Rare Disease Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Rare Disease Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Rare Disease Therapeutic Market Share by Region (2020-2025)
Table 9. Global Rare Disease Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Rare Disease Therapeutic Market Share by Region (2026-2031)
Table 11. Rare Disease Therapeutic Market Trends
Table 12. Rare Disease Therapeutic Market Drivers
Table 13. Rare Disease Therapeutic Market Challenges
Table 14. Rare Disease Therapeutic Market Restraints
Table 15. Global Rare Disease Therapeutic Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Rare Disease Therapeutic Market Share by Players (2020-2025)
Table 17. Global Top Rare Disease Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Therapeutic as of 2024)
Table 18. Ranking of Global Top Rare Disease Therapeutic Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Rare Disease Therapeutic Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Rare Disease Therapeutic, Headquarters and Area Served
Table 21. Global Key Players of Rare Disease Therapeutic, Product and Application
Table 22. Global Key Players of Rare Disease Therapeutic, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rare Disease Therapeutic Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Rare Disease Therapeutic Revenue Market Share by Type (2020-2025)
Table 26. Global Rare Disease Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Rare Disease Therapeutic Revenue Market Share by Type (2026-2031)
Table 28. Global Rare Disease Therapeutic Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Rare Disease Therapeutic Revenue Market Share by Application (2020-2025)
Table 30. Global Rare Disease Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Rare Disease Therapeutic Revenue Market Share by Application (2026-2031)
Table 32. North America Rare Disease Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Rare Disease Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Rare Disease Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Rare Disease Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Rare Disease Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Rare Disease Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Rare Disease Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Rare Disease Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Rare Disease Therapeutic Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Rare Disease Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Rare Disease Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Rare Disease Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Rare Disease Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Rare Disease Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Rare Disease Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 47. Bristol-Myers Squibb Company Details
Table 48. Bristol-Myers Squibb Business Overview
Table 49. Bristol-Myers Squibb Rare Disease Therapeutic Product
Table 50. Bristol-Myers Squibb Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 51. Bristol-Myers Squibb Recent Development
Table 52. Bayer Company Details
Table 53. Bayer Business Overview
Table 54. Bayer Rare Disease Therapeutic Product
Table 55. Bayer Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 56. Bayer Recent Development
Table 57. AstraZeneca Company Details
Table 58. AstraZeneca Business Overview
Table 59. AstraZeneca Rare Disease Therapeutic Product
Table 60. AstraZeneca Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 61. AstraZeneca Recent Development
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Rare Disease Therapeutic Product
Table 65. Pfizer Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Novo Nordisk A/S Company Details
Table 68. Novo Nordisk A/S Business Overview
Table 69. Novo Nordisk A/S Rare Disease Therapeutic Product
Table 70. Novo Nordisk A/S Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 71. Novo Nordisk A/S Recent Development
Table 72. Sanofi SA Company Details
Table 73. Sanofi SA Business Overview
Table 74. Sanofi SA Rare Disease Therapeutic Product
Table 75. Sanofi SA Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 76. Sanofi SA Recent Development
Table 77. AbbVie Company Details
Table 78. AbbVie Business Overview
Table 79. AbbVie Rare Disease Therapeutic Product
Table 80. AbbVie Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 81. AbbVie Recent Development
Table 82. F Hoffmann-La Roche Company Details
Table 83. F Hoffmann-La Roche Business Overview
Table 84. F Hoffmann-La Roche Rare Disease Therapeutic Product
Table 85. F Hoffmann-La Roche Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 86. F Hoffmann-La Roche Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Rare Disease Therapeutic Product
Table 90. Amgen Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. Eisai Company Details
Table 93. Eisai Business Overview
Table 94. Eisai Rare Disease Therapeutic Product
Table 95. Eisai Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 96. Eisai Recent Development
Table 97. Novartis AG Company Details
Table 98. Novartis AG Business Overview
Table 99. Novartis AG Rare Disease Therapeutic Product
Table 100. Novartis AG Revenue in Rare Disease Therapeutic Business (2020-2025) & (US$ Million)
Table 101. Novartis AG Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Rare Disease Therapeutic Picture
Figure 2. Global Rare Disease Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rare Disease Therapeutic Market Share by Type: 2024 VS 2031
Figure 4. Biologics Features
Figure 5. Biosimilar Features
Figure 6. Small Molecules Features
Figure 7. Global Rare Disease Therapeutic Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Rare Disease Therapeutic Market Share by Application: 2024 VS 2031
Figure 9. Hematologic Disease Case Studies
Figure 10. Cancer Case Studies
Figure 11. Infectious Disease Case Studies
Figure 12. Cardiovascular Disease Case Studies
Figure 13. Metabolic Disease Case Studies
Figure 14. Endocrine Disease Case Studies
Figure 15. Musculoskeletal Disease Case Studies
Figure 16. Others Case Studies
Figure 17. Rare Disease Therapeutic Report Years Considered
Figure 18. Global Rare Disease Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Rare Disease Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Rare Disease Therapeutic Market Share by Region: 2024 VS 2031
Figure 21. Global Rare Disease Therapeutic Market Share by Players in 2024
Figure 22. Global Top Rare Disease Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Therapeutic as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Rare Disease Therapeutic Revenue in 2024
Figure 24. North America Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Rare Disease Therapeutic Market Share by Country (2020-2031)
Figure 26. United States Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Rare Disease Therapeutic Market Share by Country (2020-2031)
Figure 30. Germany Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Rare Disease Therapeutic Market Share by Region (2020-2031)
Figure 38. China Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Rare Disease Therapeutic Market Share by Country (2020-2031)
Figure 46. Mexico Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Rare Disease Therapeutic Market Share by Country (2020-2031)
Figure 50. Turkey Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Rare Disease Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 54. Bayer Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 55. AstraZeneca Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 56. Pfizer Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 57. Novo Nordisk A/S Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 58. Sanofi SA Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 59. AbbVie Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 60. F Hoffmann-La Roche Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 61. Amgen Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 62. Eisai Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 63. Novartis AG Revenue Growth Rate in Rare Disease Therapeutic Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
